Showing results (321-330 of 466) with videos related to
Sort By:
Pageof 47
Blood|March 15, 1996
Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantationS Slavin, E Naparstek, A Nagler, et al.Experimental Hematology|October 1, 1996
Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in miceA Abdul-Hai, R Or, S Slavin, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1979
Characterization of a spontaneous murine B cell leukemia (BCL1). I. Cell surface expression of IgM, IgD, Ia, and FcRM R Knapp, P P Jones, S J Black, et al.Annals of Internal Medicine|July 1, 1986
Total lymphoid irradiation in refractory systemic lupus erythematosusE Ben-Chetrit, D J Gross, A Braverman, et al.Clinical and Experimental Immunology|August 1, 1994
Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donorsY Ilan, A Nagler, D Shouval, et al.Bone Marrow Transplantation|January 1, 1994
Total lymphoid irradiation, anti-lymphocyte globulin and Campath 1-G for immunosuppression prior to bone marrow transplantation for aplastic anemia after repeated graft rejectionR Or, J Mehta, J Kapelushnik, et al.Experimental Hematology|July 10, 1998
Enhanced lymphoid cell recovery after bone marrow transplantation: correlation with the presence of costimulatory antibodies in serumA Bishara, M Aker, A Amar, et al.Hepatology (Baltimore, Md.)|August 1, 1993
Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantationY Ilan, A Nagler, R Adler, et al.Acta Haematologica|October 30, 1998
Continuous interleukin-2 infusion combined with cyclophosphamide- based combination chemotherapy in the treatment of hemato-oncological malignancies. Results of a phase I-II studyA Nagler, A Ackerstein, M Ben-Shahar, et al.International Immunopharmacology|June 16, 2001
The immunomodulator Linomide: role in treatment and prevention of autoimmune diabetes mellitusD J Gross, L Weiss, I Reibstein, et al.Pageof 47